Assessment of tumor antigen-loaded solid lipid nanoparticles as an efficient delivery system for dendritic cell engineering

Nanomedicine

Volumn 8, Issue 7, 2013, Pages 1067-1084

  Bhargava, Arpit ^a,b,c   Mishra, Dinesh ^d   Khan, Saba ^a,c   Varshney, Subodh K ^c   Banerjee, Smita ^a   Mishra, Pradyumna K ^a,b,c  

^a DR H S GOUR UNIVERSITY   (India)

^b TATA MEMORIAL HOSPITAL   (India)

^c BHOPAL MEMORIAL HOSPITAL AND RESEARCH CENTRE   (India)

^d GURU GHASIDAS UNIVERSITY   (India)

Author keywords

cancer immunotherapy; gastrointestinal cancer; immune tolerance; nanomedicine; translational oncology

Indexed keywords

SOLID LIPID NANOPARTICLE; TUMOR ANTIGEN;

APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL ENCAPSULATION; CELL ENGINEERING; CELL LYSATE; CELL STRAIN HEPG2; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; IMMUNE RESPONSE; LIVER CELL CARCINOMA; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 TH2 BALANCE; TUMOR CELL;

EID: 84879650432     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.164     Document Type: Article

References (40)

1. Huang FP, Chen YX, To CK. Guiding the "misguided"-functional conditioning of dendritic cells for the DC-based immunotherapy against tumours. Eur. J. Immunol. 41, 18-25 (2011).
2. Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene 27, 5904-5912 (2008). nn nn Provides a detailed understanding of cellular and molecular pathways operating in the tumor microenvironment.
3. Bianchi G, Borgonovo G, Pistoia V, Raffaghello L. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells. Histol. Histopathol. 26, 941-951 (2011).
4. Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance. Clin. Dev. Immunol. doi:10.1155/2011/430394 (2011) (Epub ahead of print).
5. Cheng HH, Tseng GY, Yang HB, Wang HJ, Lin HJ, Wang WC. Increased numbers of Foxp3-positive regulatory T cells in gastritis, peptic ulcer and gastric adenocarcinoma. World J. Gastroenterol. 18, 33-34 (2012)
6. Giannopoulos K, Kaminska W, Hus I, Dmoszynska A. The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma. Br. J. Cancer 106, 546-552 (2012).
7. Cantini G, Pisati F, Mastropietro A et al. A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment. Cancer Immunol. Immunother. 60, 1739-1750 (2011).
8. Flinsenberg TW, Compeer EB, Boelens JJ, Boes M. Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention. Clin. Exp. Immunol. 165, 8-18 (2011).
9. Zhang Z, Guo Y, Feng S. Nanoimmunotherapy: application of nanotechnology for sustained and targeted delivery of antigens to dendritic cells. Nanomedicine (Lond.) 7, 1-4 (2012).
10. Prasad S, Cody V, Saucier-Sawyer JK et al. Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy. Nanomedicine 7, 1-10 (2011).
11. Cho NH, Cheong TC, Min JH et al. A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy. Nat. Nanotechnol. 6, 675-682 (2011).
12. Mishra H, Mishra D, Mishra PK, Nahar M, Dubey V, Jain NK. Evaluation of solid lipid nanoparticles as carriers for delivery of hepatitis B surface antigen for vaccination using subcutaneous route. J. Pharm. Pharm. Sci. 13, 495-509 (2010).
13. Pandit AA, Dash AK. Surface-modified solid lipid nanoparticulate formulation for ifosfamide: development and characterization. Nanomedicine (Lond.) 6, 1397-1412 (2011).
14. Bondì ML, Craparo EF, Giammona G, Drago F. Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. Nanomedicine (Lond.) 5, 25-32 (2010).
15. Jain D, Pathak N, Khan S et al. Evaluation of cytotoxicity and anticarcinogenic potential of Mentha leaf extracts. Int. J. Toxicol. 30, 225-236 (2011).
16. Mishra D, Mishra PK, Dabadghao S, Dubey V, Nahar M, Jain NK. Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response. Nanomedicine 6, 110-118 (2010).
17. Liu BY, Chen XH, Gu QL et al. Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer. World J. Gastroenterol. 10, 630-633 (2004).
18. Tobiásová Z, Pospísilová D, Miller AM et al. In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients. Clin. Immunol. 122, 18-27 (2007). (Pubitemid 46039753)
19. Mishra PK, Bhargava A, Raghuram GV et al. Induction of genomic instability in cultured human colon epithelial cells following exposure to isocyanates. Cell Biol. Int. 33, 675-683 (2009).
20. Mishra PK, Raghuram GV, Bhargava A et al. In vitro and in vivo evaluation of the anticarcinogenic and cancer chemopreventive potential of a flavonoid-rich fraction from a traditional Indian herb Selaginella bryopteris. Br. J. Nutr. 106, 1154-1168 (2011).
21. Chiang CL, Hagemann AR, Leskowitz R et al. Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses . PLoS ONE 6, e28732 (2011).
22. Mishra D, Mishra PK, Dubey V, Dabadghao S, Jain NK. Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigen-loaded elastic liposomes. Vaccine 25, 6939-6944 (2007). (Pubitemid 47391101)
23. Bhargava A, Raghuram GV, Pathak N et al. Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response. Free Radic. Biol. Med. 51, 1806-1814 (2011).
24. Mishra D, Mishra PK, Dubey V, Nahar M, Dabadghao S, Jain NK. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes. Eur. J. Pharm. Sci. 33, 424-433 (2008).
25. Khan S, Raghuram GV, Bhargava A et al. Role and clinical significance of lymphocyte mitochondrial dysfunction in type 2 diabetes mellitus. Transl. Res. 158, 344-359 (2011).
26. Ponti D, Costa A, Zaffaroni N et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 65, 5506-5511 (2005). (Pubitemid 40911148)
27. Qiu J, Li GW, Sui YF, Song HP, Si SY, Ge W. Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo. World J. Gastroenterol. 12, 473-478 (2006). (Pubitemid 43329270)
28. Nahar M, Dubey V, Mishra D, Mishra PK, Dube A, Jain NK. In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis. J. Drug Target 18, 93-105 (2010).
29. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J. Clin. 61, 69-90 (2011).
30. Mishra PK, Raghuram GV, Jatawa SK et al. Frequency of genetic alterations observed in cell cycle regulatory proteins and microsatellite instability in gallbladder adenocarcinoma: a translational perspective. Asian Pac. J. Cancer Prev. 12, 573-574 (2011).
31. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev. 19, 1893-1907 (2010).
32. Mishra PK, Jatawa SK, Raghuram GV et al. Correlation of aberrant expression of p53, Rad50, and cyclin-E proteins with microsatellite instability in gallbladder adenocarcinomas. Genet. Mol. Res. 8, 1202-1210 (2009).
33. Chaudhuri, D, Suriano R, Mittelman A, Tiwari RK. Targeting the immune system in cancer. Curr. Pharm. Biotechnol. 10, 166-184 (2009).
34. Bhargava A, Mishra D, Banerjee S, Mishra PK. Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation. Immunotherapy 4, 703-718 (2012).
35. Zhang LW, Bäumer W, Monteiro-Riviere NA. Cellular uptake mechanisms and toxicity of quantum dots in dendritic cells. Nanomedicine (Lond.) 6, 777-791 (2011).
36. Horev-Azaria L, Kirkpatrick CJ, Korenstein R et al. Predictive toxicology of cobalt nanoparticles and ions: comparative in vitro study of different cellular models using methods of knowledge discovery from data. Toxicol. Sci. 122, 489-501 (2011).
37. Di Gioacchino M, Petrarca C, Lazzarin F et al. Immunotoxicity of nanoparticles. Int. J. Immunopathol. Pharmacol. 24(Suppl. 1), 65S-71S (2011).
38. Tan G, Wang Z, Zhang X, Cai Z, Zhang J. Induction of CTLs by DCs pulsed with K-ras mutant peptide on the surface of nanoparticles in the treatment of pancreatic cancer. Oncol. Rep. 26, 215-221 (2011).
39. Lengagne R, Pommier A, Caron J et al. T cells contribute to tumor progression by favoring pro-tumoral properties of intra-tumoral myeloid cells in a mouse model for spontaneous melanoma. PLoS ONE 6(5), e20235 (2011).
40. Kim KS, Pham TN, Jin CJ et al. Uncarinic acid C isolated from uncaria rhynchophylla induces differentiation of Th1-promoting dendritic cells through TLR4 signaling. Biomark. Insights 6, 27-38 (2011).